EMMA MUHLSTEIN: Open Payments
NPI 1972223246 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 33 payments from 14 companies in 2025. Trend: 2023 $709 · 2024 $775 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $118 |
| Astellas Pharma US Inc | 4 | $110 |
| Biogen, Inc. | 3 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $66 |
| MILLICENT US INC | 2 | $33 |
| Organon LLC | 2 | $32 |
| PFIZER INC. | 2 | $32 |
| ViiV Healthcare Company | 1 | $29 |
| Exeltis, USA Inc. | 2 | $28 |
Products named: Veozah, ZURZUVAE, LILETTA, INTRAROSA, NEXPLANON, ABRYSVO, APRETUDE, SLYND.
Industry payments across AZ — which companies pay providers there.
